Thompson Davis & Co’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-369	Closed	-$52K	–	1166
2017 Q3	$52K	Sell	369 -206	-36%	-$28K	0.09%	230
2017 Q2	$70K	Buy	575 +310	+117%	+$36.1K	0.11%	174
2017 Q1	$32K	Sell	265 -11	-4%	-$1.42K	0.05%	343
2016 Q4	$34K	Buy	276 +37	+15%	+$4.53K	0.06%	318
2016 Q3	$29K	Buy	239 +40	+20%	+$5.15K	0.05%	362
2016 Q2	$23K	Sell	199 -2	-1%	-$284	0.04%	427
2016 Q1	$28K	Sell	201 -1	-0.5%	-$147	0.04%	355
2015 Q4	$39K	Hold	202	–	–	0.06%	300
2015 Q3	$32K	Buy	202 +50	+33%	+$9.12K	0.04%	347
2015 Q2	$27K	Buy	152 +29	+24%	+$5K	0.03%	466
2015 Q1	$21K	Buy	123 +9	+8%	+$1.63K	0.03%	520
2014 Q4	$21K	Buy	114 +17	+18%	+$3.15K	0.02%	504
2014 Q3	$16K	Buy	+97	New	+$15.9K	0.02%	543
2014 Q2	–	Sell	-24	Closed	-$4K	–	897
2014 Q1	$4K	Sell	24 -750	-97%	-$119K	0.01%	685
2013 Q4	$103K	Buy	+774	New	+$92.9K	0.16%	150